Transpara vs syngo.CT Extended Functionality

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Transpara

by ScreenPoint Medical B.V.

syngo.CT Extended Functionality

by Siemens Medical Solutions USA

AI Verdict

Transpara is an AI-powered solution specifically designed for breast cancer detection and workflow optimization in 2D and 3D mammography. In contrast, syngo.CT Extended Functionality is a broader advanced visualization software for various medical images, including CT and MR, offering general qualitative and quantitative analysis tools. While both are FDA-cleared radiology AI tools, Transpara's specialized focus on mammography makes it a more direct competitor for breast imaging needs, whereas syngo.CT Extended Functionality offers a wider range of general imaging analysis capabilities across different modalities.

Choose Transpara if…

Choose Transpara if your primary goal is to enhance breast cancer detection rates and optimize radiologist workflow in mammography. This AI solution is particularly well-suited for screening programs, offering features like temporal comparison, breast density assessment, and risk categorization to aid in earlier detection and reduce radiologist workload.

View Transpara →

Choose syngo.CT Extended Functionality if…

Choose syngo.CT Extended Functionality if your focus is on advanced visualization and quantitative analysis across various medical imaging modalities, especially CT. This tool is ideal for complex diagnostic evaluations requiring features like bone removal for CT angiography, phase creation, motion correction, and 4D noise reduction to improve image quality and support detailed clinical assessments.

View syngo.CT Extended Functionality →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Transpara	syngo.CT Extended Functionality
Pricing	Enterprise	Contact for pricing
Deployment	On premise	On-premise workstation software, potentially integrating with client-server solutions like syngo.via
FDA Status	Cleared AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Transpara

Transpara emphasizes user experience and workflow optimization, with features like concurrent reading aid and workload reduction. Testimonials highlight increased diagnostic confidence and a preference for not working without it. While syngo.CT Extended Functionality offers advanced visualization tools, there is less explicit information available regarding its direct impact on radiologist workflow efficiency or user-reported ease of use.

Clinical Value

Transpara

Transpara has a strong emphasis on clinical validation, with over 55 peer-reviewed publications and being the first breast AI solution validated by a randomized controlled trial (MASAI study). This trial demonstrated a 29% increase in cancer detection and a 44% workload reduction. While syngo.CT Extended Functionality is FDA-cleared and provides advanced visualization for diagnosis, the available information does not detail specific clinical outcome improvements or large-scale randomized controlled trials demonstrating similar levels of impact on detection rates or workload reduction.

Pricing & Value

Tie

Both tools utilize an 'enterprise custom pricing' or 'contact for pricing' model, making a direct comparison of cost-effectiveness difficult without specific quotes. While Transpara mentions potential cost savings and increased quality-adjusted life years in a simulated economic analysis, syngo.CT Extended Functionality does not provide comparable public information regarding its economic value proposition.

Enterprise Readiness

Transpara

Transpara is deployed in 'hundreds of leading centers in 30+ countries' and has analyzed over 11 million mammograms, indicating broad adoption and proven scalability for large health systems. It also offers an API for integration and data export capabilities. While syngo.CT Extended Functionality is from Siemens, a major healthcare technology company, and is likely robust for enterprise use, the provided information does not offer comparable metrics on its global deployment scale or specific integration features like an API.

Innovation

Transpara

Transpara demonstrates innovation through its AI-powered detection for both 2D and 3D mammography, including advanced features like Temporal Comparison (analyzing current against up to 3 prior studies over 6 years) and comprehensive breast density assessment. It also highlights continuous updates and new feature releases. syngo.CT Extended Functionality offers advanced visualization and quantitative analysis tools, including bone removal and motion correction, but these appear to be more established functionalities within advanced imaging software rather than groundbreaking AI innovations in the same vein as Transpara's specialized breast AI.

Support & Docs

Transpara

Transpara explicitly mentions comprehensive support including documentation/knowledge base, support requests, and online training, with a focus on proactive support and frequent updates. They also provide multiple contact methods and emphasize customer satisfaction. While Siemens (syngo.CT Extended Functionality's company) generally offers extensive support, specific details about the documentation, training, and responsiveness for this particular product are not readily available in the provided information to make a direct comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Transpara	syngo.CT Extended Functionality
Name	Transpara	syngo.CT Extended Functionality
Company	ScreenPoint Medical B.V.	Siemens Medical Solutions USA
Primary Modality Focus	2D and 3D mammography (FFDM and DBT)	CT and other medical images (e.g., MR)
Key Feature 1	AI-powered detection for 2D and 3D mammograms	Advanced visualization tools for medical images
Key Feature 2	Temporal Comparison (analyzes current study against up to 3 priors over 6 years)	Qualitative and quantitative measurements
Key Feature 3	Breast Density assessment (BI-RADS-like and volumetric)	Analysis of clinical data from CT and other modalities (e.g., MR)

Videos

Demos, reviews, and walkthroughs featuring Transpara and syngo.CT Extended Functionality.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows and EHR systems?

Transpara is designed for concurrent reading, providing risk-based analysis as radiologists review mammograms and integrating into existing radiology workflows, including PACS. syngo.CT Extended Functionality is workstation software that offers advanced visualization and quantitative analysis tools for CT and other medical images, with an interface to connect to interconnected CT scanner systems.

What are the reported accuracy and sensitivity for each tool in their respective specialties?

Transpara has demonstrated improved breast cancer detection accuracy for radiologists, with studies showing higher mean areas under the receiver operating characteristic curves and comparable sensitivity and specificity compared to unaided reading. It has a high negative predictive value of 99.97% for low-risk cases. syngo.CT Extended Functionality provides advanced visualization and quantitative measurement tools to assist in diagnosis across various CT and other medical imaging modalities.

What is the typical learning curve for physicians adopting each tool?

Transpara's interface is designed to be user-friendly, allowing radiologists to adopt the technology without significant disruption to their existing workflow. syngo.CT Extended Functionality is a software bundle with various extensions for specialized clinical evaluations, implying a learning curve associated with mastering its advanced visualization and analysis tools.

What kind of customer support can physicians expect for each tool?

Transpara offers customer support via email and phone, with testimonials highlighting positive experiences with their support team. Information regarding specific customer support details for syngo.CT Extended Functionality is not explicitly provided in the given data, but Siemens Medical Solutions is a large company, suggesting established support channels.

How do these tools contribute to time-to-value and efficiency in a clinical setting?

Transpara aims to improve workflow efficiency by reducing the time spent on low-risk mammograms (up to 26% overall) due to its high negative predictive value, allowing radiologists to focus on higher-risk cases. Studies have shown Transpara can lead to a 44% reduction in screen-reading workload while increasing cancer detection by 29%. syngo.CT Extended Functionality enhances diagnostic precision and patient care through advanced CT clinical applications and operational optimization.

What security measures beyond HIPAA are in place for each tool, and what audit-trail features are available?

Transpara's integration with platforms like Microsoft for Healthcare's Precision Imaging Network leverages Microsoft's security and scalability. Transpara also offers the ability for healthcare systems to validate the algorithm against their own local data before full clinical implementation, which helps monitor outcomes and performance over time. While specific audit-trail features for Transpara are not detailed, a comprehensive audit trail typically includes user identification, actions performed, and timestamps for accountability and compliance. Details on syngo.CT Extended Functionality's security measures beyond HIPAA and specific audit-trail features are not provided in the given information.